Feb. 17, 2009--Today Nycomed received an expanded indication for TachoSil, its innovative surgical patch, from the European Medicines Agency. To date, TachoSil was approved for haemostasis (control of bleeding) in surgery. With the new expanded indication, it becomes the first and only dual action patch approved for haemostasis, tissue sealing as well as for suture support in vascular surgery.
The details can be read here.
No comments:
Post a Comment